3'LIFE: A functional assay to detect miRNA targets in high-throughput

Nucleic Acids Research

Volumn 42, Issue 17, 2014, Pages

  Wolter, Justin M ^a,b   Kotagama, Kasuen ^a,b   Pierre Bez, Alexandra C ^b   Firago, Mari ^a   Mangone, Marco ^a,b  

^a ARIZONA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; HEAT SHOCK TRANSCRIPTION FACTOR 1; MESSENGER RNA; MICRORNA; MICRORNA 10B; MICRORNA LET 7C; STAT6 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOASSAY; BIOINFORMATICS; COMPARATIVE STUDY; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; GENE; GENE LIBRARY; GENE OVEREXPRESSION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRANSFECTION; HEK293 CELL LINE; HIGH THROUGHPUT SEQUENCING; HOXD GENE; HUMAN; LUMINESCENT IDENTIFICATION OF FUNCTIONAL ELEMENTS IN 3' UNTRANSLATED REGION; MOLECULAR INTERACTION; NON CANONICAL INTERACTION; ONCOGENE K RAS; ONCOGENE N RAS; PREDICTIVE VALUE; PRIORITY JOURNAL; RNA PROCESSING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; CHEMISTRY; GENETICS; LUMINESCENCE; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; PROCEDURES;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CONSERVED SEQUENCE; HEK293 CELLS; HUMANS; LUMINESCENT MEASUREMENTS; MICRORNAS; NEOPLASMS; RNA, MESSENGER;

EID: 84964315907     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku626     Document Type: Article

References (115)

1. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
2. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-854.
3. Garzon, R., Marcucci, G. and Croce, C.M. (2010) Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov., 9, 775-789.
4. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
5. Friedman, R.C., Farh, K.K., Burge, C.B. and Bartel, D.P. (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 19, 92-105.
6. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell, 115, 787-798.
7. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
8. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500.
9. Easow, G., Teleman, A.A. and Cohen, S.M. (2007) Isolation of microRNA targets by miRNP immunopurification. RNA, 13, 1198-1204.
10. Selbach, M., Schwanhausser, B., Thierfelder, N., Fang, Z., Khanin, R. and Rajewsky, N. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature, 455, 58-63.
11. Zhou, P., Xu, W., Peng, X., Luo, Z., Xing, Q., Chen, X., Hou, C., Liang, W., Zhou, J., Wu, X. et al. (2013) Large-scale screens of miRNA-mRNA interactions unveiled that the 3'UTR of a gene is targeted by multiple miRNAs. PLoS ONE, 8, e68204.
12. Chi, S.W., Hannon, G.J. and Darnell, R.B. (2012) An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol., 19, 321-327.
13. Baek, D., Villen, J., Shin, C., Camargo, F.D., Gygi, S.P. and Bartel, D.P. (2008) The impact of microRNAs on protein output. Nature, 455, 64-71.
14. Azzouzi, I., Moest, H., Winkler, J., Fauchere, J.C., Gerber, A.P., Wollscheid, B., Stoffel, M., Schmugge, M. and Speer, O. (2011) MicroRNA-96 directly inhibits gamma-globin expression in human erythropoiesis. PLoS ONE, 6, e22838.
15. Cevec, M., Thibaudeau, C. and Plavec, J. (2010) NMR structure of the let-7 miRNA interacting with the site LCS1 of lin-41 mRNA from Caenorhabditis elegans. Nucleic Acids Res., 38, 7814-7821.
16. Chen, J., Zhang, X., Lentz, C., Abi-Daoud, M., Pare, G.C., Yang, X., Feilotter, H.E. and Tron, V.A. (2011) miR-193b Regulates Mcl-1 in Melanoma. Am. J. Pathol., 179, 2162-2168.
17. Jiao, L.R., Frampton, A.E., Jacob, J., Pellegrino, L., Krell, J., Giamas, G., Tsim, N., Vlavianos, P., Cohen, P., Ahmad, R. et al. (2012) MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS ONE, 7, e32068.
18. Lal, A., Navarro, F., Maher, C.A., Maliszewski, L.E., Yan, N., O'Day, E., Chowdhury, D., Dykxhoorn, D.M., Tsai, P., Hofmann, O. et al. (2009) miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell, 35, 610-625.
19. Wu, L. and Belasco, J.G. (2005) Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol. Cell. Biol., 25, 9198-9208.
20. Shin, C., Nam, J.W., Farh, K.K., Chiang, H.R., Shkumatava, A. and Bartel, D.P. (2010) Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell, 38, 789-802.
21. Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M. Jr, Jungkamp, A.C., Munschauer, M. et al. (2010) Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell, 141, 129-141.
22. Majoros, W.H., Lekprasert, P., Mukherjee, N., Skalsky, R.L., Corcoran, D.L., Cullen, B.R. and Ohler, U. (2013) MicroRNA target site identification by integrating sequence and binding information. Nat. Methods, 10, 630-633.
23. Dyer, B.W., Ferrer, F.A., Klinedinst, D.K. and Rodriguez, R. (2000) A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem., 282, 158-161.
24. Boutz, D.R., Collins, P.J., Suresh, U., Lu, M., Ramirez, C.M., Fernandez-Hernando, C., Huang, Y., Abreu Rde, S., Le, S.Y., Shapiro, B.A. et al. (2011) Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J. Biol. Chem., 286, 18066-18078.
25. Gaken, J., Mohamedali, A.M., Jiang, J., Malik, F., Stangl, D., Smith, A.E., Chronis, C., Kulasekararaj, A.G., Thomas, N.S., Farzaneh, F. et al. (2012) A functional assay for microRNA target identification and validation. Nucleic Acids Res., 40, e75.
26. Shell, S., Park, S.M., Radjabi, A.R., Schickel, R., Kistner, E.O., Jewell, D.A., Feig, C., Lengyel, E. and Peter, M.E. (2007) Let-7 expression defines two differentiation stages of cancer. Proc. Natl Acad. Sci. U.S.A., 104, 11400-11405.
27. Childs, G., Fazzari, M., Kung, G., Kawachi, N., Brandwein-Gensler, M., McLemore, M., Chen, Q., Burk, R.D., Smith, R.V., Prystowsky, M.B. et al. (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol., 174, 736-745.
28. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y. et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res., 64, 3753-3756.
29. Sakurai, M., Miki, Y., Masuda, M., Hata, S., Shibahara, Y., Hirakawa, H., Suzuki, T. and Sasano, H. (2012) LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J. Steroid Biochem. Mol. Biol., 131, 101-106.
30. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D. and Slack, F.J. (2005) RAS is regulated by the let-7 microRNA family. Cell, 120, 635-647.
31. Papaioannou, G., Inloes, J.B., Nakamura, Y., Paltrinieri, E. and Kobayashi, T. (2013) let-7 and miR-140 microRNAs coordinately regulate skeletal development. Proc. Natl Acad. Sci. U.S.A., 110, E3291-E3300.
32. Umemura, S., Shirane, M., Takekoshi, S., Kusakabe, T., Itoh, J., Egashira, N., Tokuda, Y., Mori, K. and Osamura, Y.R. (2009) Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome. Br. J. Cancer, 100, 764-771.
33. Han, H.B., Gu, J., Zuo, H.J., Chen, Z.G., Zhao, W., Li, M., Ji, D.B., Lu, Y.Y. and Zhang, Z.Q. (2012) Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J. Pathol., 226, 544-555.
34. Ma, L., Teruya-Feldstein, J. and Weinberg, R.A. (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449, 682-688.
35. Bourguignon, L.Y., Wong, G., Earle, C., Krueger, K. and Spevak, C.C. (2010) Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J. Biol. Chem., 285, 36721-36735.
36. Foley, N.H., Bray, I., Watters, K.M., Das, S., Bryan, K., Bernas, T., Prehn, J.H. and Stallings, R.L. (2011) MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ., 18, 1089-1098.
37. Gabriely, G., Teplyuk, N.M. and Krichevsky, A.M. (2011) Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy, 7, 1384-1386.
38. Nakata, K., Ohuchida, K., Mizumoto, K., Kayashima, T., Ikenaga, N., Sakai, H., Lin, C., Fujita, H., Otsuka, T., Aishima, S. et al. (2011) MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery, 150, 916-922.
39. Sun, L., Yan, W., Wang, Y., Sun, G., Luo, H., Zhang, J., Wang, X., You, Y., Yang, Z. and Liu, N. (2011) MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res., 1389, 9-18.
40. Hsu, S.D., Lin, F.M., Wu, W.Y., Liang, C., Huang, W.C., Chan, W.L., Tsai, W.T., Chen, G.Z., Lee, C.J., Chiu, C.M. et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res., 39, D163-D169.
41. Tian, Y., Luo, A., Cai, Y., Su, Q., Ding, F., Chen, H. and Liu, Z. (2010) MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem., 285, 7986-7994.
42. Paraskevopoulou, M.D., Georgakilas, G., Kostoulas, N., Vlachos, I.S., Vergoulis, T., Reczko, M., Filippidis, C., Dalamagas, T. and Hatzigeorgiou, A.G. (2013) DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res., 41, W169-W173.
43. Vergoulis, T., Vlachos, I.S., Alexiou, P., Georgakilas, G., Maragkakis, M., Reczko, M., Gerangelos, S., Koziris, N., Dalamagas, T. and Hatzigeorgiou, A.G. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res., 40, D222-D229.
44. Seiler, C.Y., Park, J.G., Sharma, A., Hunter, P., Surapaneni, P., Sedillo, C., Field, J., Algar, R., Price, A., Steel, J. et al. (2014) DNASU plasmid and PSI: Biology-Materials repositories: resources to accelerate biological research. Nucleic Acids Res., 42, D1253-D1260.
45. Qiu, L., Wang, H., Xia, X., Zhou, H. and Xu, Z. (2008) A construct with fluorescent indicators for conditional expression of miRNA. BMC Biotechnol., 8, 77.
46. Mangone, M., Manoharan, A.P., Thierry-Mieg, D., Thierry-Mieg, J., Han, T., Mackowiak, S.D., Mis, E., Zegar, C., Gutwein, M.R., Khivansara, V. et al. (2010) The landscape of C. elegans 3'UTRs. Science, 329, 432-435.
47. Takagaki, Y. and Manley, J.L. (1997) RNA recognition by the human polyadenylation factor CstF. Mol. Cell. Biol., 17, 3907-3914.
48. Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, R. et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics, 23, 2947-2948.
49. Crooks, G.E., Hon, G., Chandonia, J.M. and Brenner, S.E. (2004) WebLogo: a sequence logo generator. Genome Res., 14, 1188-1190.
50. Helwak, A., Kudla, G., Dudnakova, T. and Tollervey, D. (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell, 153, 654-665.
51. Pollard, K.S., Hubisz, M.J., Rosenbloom, K.R. and Siepel, A. (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res., 20, 110-121.
52. Qin, J.Y., Zhang, L., Clift, K.L., Hulur, I., Xiang, A.P., Ren, B.Z. and Lahn, B.T. (2010) Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PLoS ONE, 5, e10611.
53. Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P. and Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 27, 91-105.
54. Farh, K.K., Grimson, A., Jan, C., Lewis, B.P., Johnston, W.K., Lim, L.P., Burge, C.B. and Bartel, D.P. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-1821.
55. Nielsen, C.B., Shomron, N., Sandberg, R., Hornstein, E., Kitzman, J. and Burge, C.B. (2007) Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA, 13, 1894-1910.
56. Bhattacharyya, S.N., Habermacher, R., Martine, U., Closs, E.I. and Filipowicz, W. (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 125, 1111-1124.
57. Fu, Y., Dominissini, D., Rechavi, G. and He, C. (2014) Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat. Rev. Genet., 15, 293-306.
58. Shepard, P.J., Choi, E.A., Lu, J., Flanagan, L.A., Hertel, K.J. and Shi, Y. (2011) Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq. RNA, 17, 761-772.
59. Yan, J. and Marr, T.G. (2005) Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. Genome Res., 15, 369-375.
60. Mayr, C. and Bartel, D.P. (2009) Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell, 138, 673-684.
61. Sandberg, R., Neilson, J.R., Sarma, A., Sharp, P.A. and Burge, C.B. (2008) Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science, 320, 1643-1647.
62. Lin, Y., Li, Z., Ozsolak, F., Kim, S.W., Arango-Argoty, G., Liu, T.T., Tenenbaum, S.A., Bailey, T., Monaghan, A.P., Milos, P.M. et al. (2012) An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res., 40, 8460-8471.
63. Ebert, M.S. and Sharp, P.A. (2012) Roles for MicroRNAs in conferring robustness to biological processes. Cell, 149, 515-524.
64. Pelaez, N. and Carthew, R.W. (2012) Biological robustness and the role of microRNAs: a network perspective. Curr. Top. Dev. Biol., 99, 237-255.
65. Berezikov, E. (2011) Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet., 12, 846-860.
66. Xu, J., Zhang, R., Shen, Y., Liu, G., Lu, X. and Wu, C.I. (2013) The evolution of evolvability in microRNA target sites in vertebrates. Genome Res., 23, 1810-1816.
67. Chen, K. and Rajewsky, N. (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat. Rev. Genet., 8, 93-103.
68. Chin, L.J., Ratner, E., Leng, S., Zhai, R., Nallur, S., Babar, I., Muller, R.U., Straka, E., Su, L., Burki, E.A. et al. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer Res., 68, 8535-8540.
69. Medale-Giamarchi, C., Lajoie-Mazenc, I., Malissein, E., Meunier, E., Couderc, B., Berge, Y., Filleron, T., Keller, L., Marty, C., Lacroix-Triki, M. et al. (2013) RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor. Breast Cancer Res., 15, R6.
70. Kazerounian, S., Gerald, D., Huang, M., Chin, Y.R., Udayakumar, D., Zheng, N., O'Donnell, R.K., Perruzzi, C., Mangiante, L., Pourat, J. et al. (2013) RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res., 73, 50-61.
71. Ridley, A.J. (2013) RhoA, RhoB and RhoC have different roles in cancer cell migration. J. Microsc., 251, 242-249.
72. Shepelev, M.V. and Korobko, I.V. (2013) The RHOV gene is overexpressed in human non-small cell lung cancer. Cancer Genet., 206, 393-397.
73. Pillai, S., Rizwani, W., Li, X., Rawal, B., Nair, S., Schell, M.J., Bepler, G., Haura, E., Coppola, D. and Chellappan, S. (2011) ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Mol. Cell. Biol., 31, 3052-3067.
74. Kalas, W., Yu, J.L., Milsom, C., Rosenfeld, J., Benezra, R., Bornstein, P. and Rak, J. (2005) Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras. Cancer Res., 65, 8878-8886.
75. Swarbrick, A., Roy, E., Allen, T. and Bishop, J.M. (2008) Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proc. Natl Acad. Sci. U.S.A., 105, 5402-5407.
76. Dai, C., Santagata, S., Tang, Z., Shi, J., Cao, J., Kwon, H., Bronson, R.T., Whitesell, L. and Lindquist, S. (2012) Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. J. Clin. Invest., 122, 3742-3754.
77. Dai, C., Whitesell, L., Rogers, A.B. and Lindquist, S. (2007) Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell, 130, 1005-1018.
78. Xi, C., Hu, Y., Buckhaults, P., Moskophidis, D. and Mivechi, N.F. (2012) Heat shock factor Hsf1 cooperates with ErbB2 (Her2/Neu) protein to promote mammary tumorigenesis and metastasis. J. Biol. Chem., 287, 35646-35657.
79. Stanhill, A., Levin, V., Hendel, A., Shachar, I., Kazanov, D., Arber, N., Kaminski, N. and Engelberg, D. (2006) Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells. Oncogene, 25, 1485-1495.
80. Mivechi, N.F. and Giaccia, A.J. (1995) Mitogen-activated protein kinase acts as a negative regulator of the heat shock response in NIH3T3 cells. Cancer Res., 55, 5512-5519.
81. Liu, Y., Hiraiwa, Y., Liu, E., Kurata, H., Thant, A.A., Matsuda, S. and Hamaguchi, M. (2001) Suppression of cell spreading by v-Crk requires Ras-MEK-MAP kinase signaling. Oncogene, 20, 5908-5912.
82. Mochizuki, N., Ohba, Y., Kobayashi, S., Otsuka, N., Graybiel, A.M., Tanaka, S. and Matsuda, M. (2000) Crk activation of JNK via C3G and R-Ras. J. Biol. Chem., 275, 12667-12671.
83. Peeper, D.S., Shvarts, A., Brummelkamp, T., Douma, S., Koh, E.Y., Daley, G.Q. and Bernards, R. (2002) A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol., 4, 148-153.
84. Fukuyo, Y., Takahashi, A., Hara, E., Horikoshi, N., Pandita, T.K. and Nakajima, T. (2011) E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability. Int. J. Oral Sci., 3, 200-208.
85. Wajapeyee, N., Malonia, S.K., Palakurthy, R.K. and Green, M.R. (2013) Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors. Genes Dev., 27, 2221-2226.
86. Bechtel, W., McGoohan, S., Zeisberg, E.M., Muller, G.A., Kalbacher, H., Salant, D.J., Muller, C.A., Kalluri, R. and Zeisberg, M. (2010) Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med., 16, 544-550.
87. Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C.M. and Green, M.R. (2007) An elaborate pathway required for Ras-mediated epigenetic silencing. Nature, 449, 1073-1077.
88. Fujii, S., Fukamachi, K., Tsuda, H., Ito, K., Ito, Y. and Ochiai, A. (2012) RAS oncogenic signal upregulates EZH2 in pancreatic cancer. Biochem. Biophys. Res. Commun., 417, 1074-1079.
89. Cai, H., Memarzadeh, S., Stoyanova, T., Beharry, Z., Kraft, A.S. and Witte, O.N. (2012) Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer. Cancer Res., 72, 4672-4681.
90. Min, J., Zaslavsky, A., Fedele, G., McLaughlin, S.K., Reczek, E.E., De Raedt, T., Guney, I., Strochlic, D.E., Macconaill, L.E., Beroukhim, R. et al. (2010) An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat. Med., 16, 286-294.
91. Weiss, F.U., Marques, I.J., Woltering, J.M., Vlecken, D.H., Aghdassi, A., Partecke, L.I., Heidecke, C.D., Lerch, M.M. and Bagowski, C.P. (2009) Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology, 137, 2136-2145; e2131-2137.
92. Tehler, D., Hoyland-Kroghsbo, N.M. and Lund, A.H. (2011) The miR-10 microRNA precursor family. RNA Biol., 8, 728-734.
93. Ma, L. (2010) Role of miR-10b in breast cancer metastasis. Breast Cancer Res., 12, 210.
94. Hua, S., Kittler, R. and White, K.P. (2009) Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell, 137, 1259-1271.
95. Niederreither, K. and Dolle, P. (2008) Retinoic acid in development: towards an integrated view. Nat. Rev. Genet., 9, 541-553.
96. Chen, C.F., Goyette, P. and Lohnes, D. (2004) RARgamma acts as a tumor suppressor in mouse keratinocytes. Oncogene, 23, 5350-5359.
97. Goranov, B.B., Campbell Hewson, Q.D., Pearson, A.D. and Redfern, C.P. (2006) Overexpression of RARgamma increases death of SH-SY5Y neuroblastoma cells in response to retinoic acid but not fenretinide. Cell Death Differ., 13, 676-679.
98. Spanjaard, R.A., Ikeda, M., Lee, P.J., Charpentier, B., Chin, W.W. and Eberlein, T.J. (1997) Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells. J. Biol. Chem., 272, 18990-18999.
99. Zhao, X., Graves, C., Ames, S.J., Fisher, D.E. and Spanjaard, R.A. (2009) Mechanism of regulation and suppression of melanoma invasiveness by novel retinoic acid receptor-gamma target gene carbohydrate sulfotransferase 10. Cancer Res., 69, 5218-5225.
100. Huang, G.L., Luo, Q., Rui, G., Zhang, W., Zhang, Q.Y., Chen, Q.X. and Shen, D.Y. (2013) Oncogenic activity of retinoic acid receptor gamma is exhibited through activation of the Akt/NF-kappaB and Wnt/beta-catenin pathways in cholangiocarcinoma. Mol. Cell. Biol., 33, 3416-3425.
101. Yan, T.D., Wu, H., Zhang, H.P., Lu, N., Ye, P., Yu, F.H., Zhou, H., Li, W.G., Cao, X., Lin, Y.Y. et al. (2010) Oncogenic potential of retinoic acid receptor-gamma in hepatocellular carcinoma. Cancer Res., 70, 2285-2295.
102. Battaglia, S., Maguire, O. and Campbell, M.J. (2010) Transcription factor co-repressors in cancer biology: roles and targeting. Int. J. Cancer., 126, 2511-2519.
103. Lee, S., Lee, D.K., Dou, Y., Lee, J., Lee, B., Kwak, E., Kong, Y.Y., Lee, S.K., Roeder, R.G. and Lee, J.W. (2006) Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proc. Natl Acad. Sci. U.S.A., 103, 15392-15397.
104. Kong, H.J., Yu, H.J., Hong, S., Park, M.J., Choi, Y.H., An, W.G., Lee, J.W. and Cheong, J. (2003) Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. Mol. Cancer Res., 1, 948-958.
105. Goo, Y.H., Sohn, Y.C., Kim, D.H., Kim, S.W., Kang, M.J., Jung, D.J., Kwak, E., Barlev, N.A., Berger, S.L., Chow, V.T. et al. (2003) Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins. Mol. Cell. Biol., 23, 140-149.
106. Zha, Y., Ding, E., Yang, L., Mao, L., Wang, X., McCarthy, B.A., Huang, S. and Ding, H.F. (2012) Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation. PLoS ONE, 7, e40728.
107. Merrill, R.A., Ahrens, J.M., Kaiser, M.E., Federhart, K.S., Poon, V.Y. and Clagett-Dame, M. (2004) All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biol. Chem., 385, 605-614.
108. Ishikawa, T. and Kramer, R.H. (2010) Sdc1 negatively modulates carcinoma cell motility and invasion. Exp. Cell Res., 316, 951-965.
109. Yang, Y., Shi, J., Tolomelli, G., Xu, H., Xia, J., Wang, H., Zhou, W., Zhou, Y., Das, S., Gu, Z. et al. (2013) RARalpha2 expression confers myeloma stem cell features. Blood, 122, 1437-1447.
110. Barber, N., Belov, L. and Christopherson, R.I. (2008) All-trans retinoic acid induces different immunophenotypic changes on human HL60 and NB4 myeloid leukaemias. Leuk. Res., 32, 315-322.
111. Chen, Q., Mosovsky, K.L. and Ross, A.C. (2013) Retinoic acid and alpha-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation. Immunobiology, 218, 1477-1487.
112. Gooch, J.L., Christy, B. and Yee, D. (2002) STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia, 4, 324-331.
113. Dawson, H.D., Collins, G., Pyle, R., Key, M., Weeraratna, A., Deep-Dixit, V., Nadal, C.N. and Taub, D.D. (2006) Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC immunol., 7, 27.
114. Litterst, C.M. and Pfitzner, E. (2001) Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. J. Biol. Chem., 276, 45713-45721.
115. Reijntjes, S., Francis-West, P. and Mankoo, B.S. (2010) Retinoic acid is both necessary for and inhibits myogenic commitment and differentiation in the chick limb. Int. J. Dev. Biol., 54, 125-134.